Finox Biotech is a member of the Richter Group
home
our locations

bemfola

Our vision is to develop and market high-quality, cost-effective and easy-to-use fertility products that can help patients achieve their goal of becoming parents.

bemfola r-FSH for fertility treatment

Description

BEMFOLA (development code: AFOLIA) is a recombinant-human Follic- le-Stimulating Hormone (r-FSH) and has been developed as a biosimilar to Gonal-f®, an already-marketed and established reference product

Indication

r-FSH is used to stimulate the ovaries in the context of treatment for infertility.
Gonadotropins (recombinant Follicle Stimulating Hormone (FSH) , Human Menopausal Gonadotropin (hMG) and urinary Follicle Stimulating Hormo- ne (uFSH) are the principal agents used within OI and ART treatments.

user guide animation

Media

Connect for updates

Finox Biotech is a member of the Richter Group © FINOX AG Burgdorf, Switzerland legal statement privacy policy